192 related articles for article (PubMed ID: 19038682)
1. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy.
Fujimoto S; Hartung D; Ohshima S; Edwards DS; Zhou J; Yalamanchili P; Azure M; Fujimoto A; Isobe S; Matsumoto Y; Boersma H; Wong N; Yamazaki J; Narula N; Petrov A; Narula J
J Am Coll Cardiol; 2008 Dec; 52(23):1847-1857. PubMed ID: 19038682
[TBL] [Abstract][Full Text] [Related]
2. Effect of an antimicrobial agent on atherosclerotic plaques: assessment of metalloproteinase activity by molecular imaging.
Ohshima S; Fujimoto S; Petrov A; Nakagami H; Haider N; Zhou J; Tahara N; Osako MK; Fujimoto A; Zhu J; Murohara T; Edwards DS; Narula N; Wong ND; Chandrashekhar Y; Morishita R; Narula J
J Am Coll Cardiol; 2010 Mar; 55(12):1240-1249. PubMed ID: 20298932
[TBL] [Abstract][Full Text] [Related]
3. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy.
Hartung D; Sarai M; Petrov A; Kolodgie F; Narula N; Verjans J; Virmani R; Reutelingsperger C; Hofstra L; Narula J
J Nucl Med; 2005 Dec; 46(12):2051-6. PubMed ID: 16330569
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor.
Ohshima S; Petrov A; Fujimoto S; Zhou J; Azure M; Edwards DS; Murohara T; Narula N; Tsimikas S; Narula J
J Nucl Med; 2009 Apr; 50(4):612-7. PubMed ID: 19289429
[TBL] [Abstract][Full Text] [Related]
5. Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.
Haider N; Hartung D; Fujimoto S; Petrov A; Kolodgie FD; Virmani R; Ohshima S; Liu H; Zhou J; Fujimoto A; Tahara A; Hofstra L; Narula N; Reutelingsperger C; Narula J
J Nucl Cardiol; 2009; 16(5):753-62. PubMed ID: 19662466
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive detection of matrix metalloproteinase-9 in atherosclerotic lesions using technetium-99m-labeled single-photon emission computed tomography in vivo.
Wang Z; Deng G; Zhang Z; Huang H; Zhao Y
Nucl Med Commun; 2017 Apr; 38(4):299-305. PubMed ID: 28234785
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive monitoring the biology of atherosclerotic plaque development with radiolabeled annexin V and matrix metalloproteinase inhibitor in spontaneous atherosclerotic mice.
Tekabe Y; Li Q; Luma J; Weisenberger D; Sedlar M; Harja E; Narula J; Johnson LL
J Nucl Cardiol; 2010 Dec; 17(6):1073-81. PubMed ID: 20700679
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
9. Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging.
Sarai M; Hartung D; Petrov A; Zhou J; Narula N; Hofstra L; Kolodgie F; Isobe S; Fujimoto S; Vanderheyden JL; Virmani R; Reutelingsperger C; Wong ND; Gupta S; Narula J
J Am Coll Cardiol; 2007 Dec; 50(24):2305-12. PubMed ID: 18068039
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of [
Kiugel M; Hellberg S; Käkelä M; Liljenbäck H; Saanijoki T; Li XG; Tuomela J; Knuuti J; Saraste A; Roivainen A
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513758
[No Abstract] [Full Text] [Related]
11. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled Monocyte Chemotactic Protein 1 for the detection of inflammation in experimental atherosclerosis.
Hartung D; Petrov A; Haider N; Fujimoto S; Blankenberg F; Fujimoto A; Virmani R; Kolodgie FD; Strauss HW; Narula J
J Nucl Med; 2007 Nov; 48(11):1816-21. PubMed ID: 17942805
[TBL] [Abstract][Full Text] [Related]
13. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.
Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X
Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of macrophage accumulation in statin-treated atherosclerotic mouse model using sodium iodide symporter imaging system.
Yoo RJ; Kim MH; Woo SK; Kim KI; Lee TS; Choi YK; Kang JH; Lim SM; Lee YJ
Nucl Med Biol; 2017 May; 48():45-51. PubMed ID: 28208058
[TBL] [Abstract][Full Text] [Related]
15. Montelukast inhibits matrix metalloproteinases expression in atherosclerotic rabbits.
Liu D; Ge S; Zhou G; Xu G; Zhang R; Zhu W; Liu Z; Cheng S; Liu X
Cardiovasc Drugs Ther; 2009 Dec; 23(6):431-7. PubMed ID: 19998057
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
Bai W; Zheng X; Zhou L; Li H
Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
[TBL] [Abstract][Full Text] [Related]
18. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5.
Isobe S; Tsimikas S; Zhou J; Fujimoto S; Sarai M; Branks MJ; Fujimoto A; Hofstra L; Reutelingsperger CP; Murohara T; Virmani R; Kolodgie FD; Narula N; Petrov A; Narula J
J Nucl Med; 2006 Sep; 47(9):1497-505. PubMed ID: 16954559
[TBL] [Abstract][Full Text] [Related]
20. Distribution profiles of membrane Type-1 matrix metalloproteinase (MT1-MMP), matrix metalloproteinase-2 (MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis: comparison with plaque instability analysis.
Kuge Y; Takai N; Ishino S; Temma T; Shiomi M; Saji H
Biol Pharm Bull; 2007 Sep; 30(9):1634-40. PubMed ID: 17827712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
